38.65
-0.52
(-1.33%)
At close: 5:30:07 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
Operating Cash Flow
362,000.00
362,000.00
1,223,000.00
Investing Cash Flow
-614,000.00
-614,000.00
-430,000.00
Financing Cash Flow
1,242,000.00
1,242,000.00
-769,000.00
End Cash Position
1,109,000.00
1,109,000.00
74,000.00
Capital Expenditure
-625,000.00
-625,000.00
-427,000.00
Issuance of Debt
6,449,000.00
6,449,000.00
16,000.00
Repayment of Debt
-2,627,000.00
-2,627,000.00
--
Free Cash Flow
-263,000.00
-263,000.00
796,000.00
12/31/2022 - 10/3/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SFZN.SW Siegfried Holding AG
979.00
-0.91%
GALD.SW Galderma Group N
106.98
-1.40%
MRK.DE Merck KGaA
140.65
-1.33%
PPGN.SW PolyPeptide Group AG
26.60
-2.39%
EAPI.PA Euroapi S.A.
3.1040
+0.13%
HIK.L Hikma Pharmaceuticals PLC
2,008.00
-0.69%
29A.SG Amphastar Pharmaceuticals Inc
36.20
+3.08%
068760.KQ Celltrion Pharm, Inc.
56,300.00
-1.05%
TEL1.F Sihuan Pharmaceutical Holdings Group Ltd.
0.0675
+1.50%
0ET.MU Esperion Therapeutics Inc
2.1980
+2.66%